Arbeitsgruppen
MRT Core Facility
Navigation
Arbeitsgruppen
MRT Core Facility

Aktuelle Publikationen

  • Valentin B, Schimmöller L, Ullrich T, Quentin M, Mally D, Albers P, Antoch G, Arsov C. Predictors to improve T-staging on prostate MRI at 3 Tesla. Eur Radiol 2020
  • Quentin M, Ullrich T, Dörfler S, Arsov C, Albers P, Antoch G, Schimmöller L. Preoperative MRI risk estimation and predictors of positive surgical margins in patients with prostate cancer undergoing radical prostatectomy. Eur Radiol 2020
  • Klingebiel M, Ullrich T, Quentin M, Bonekamp D, Aissa J, Mally D, Arsov C, Albers P, Antoch G, Schimmöller L. Advanced diffusion weighted imaging of the prostate: rs-EPI and ptx-EPI in comparison to standard ss-EPI sequences. Eur J Radiol 2020
  • Ziayee F, Blondin D, Irmer H, Ullrich T, Quentin M, Arsov C, Antoch G, Wittsack HJ, Schimmöller L. Impact of qualitative or quantitative analyses of dynamic contrast-enhanced MRI (DCE) for prostate cancer detection. Acta 2020
  • Ullrich T, Arsov C, Quentin M, Mones F, Westphalen AC, Mally D, Hiester A, Albers P, Antoch G, Schimmöller L. Mp-MRI can exclude prostate cancer progression in patients on Active Surveillance: A retrospective cohort-study. Eur Radiol 2020.
  • Ziayee F, Mueller-Lutz A, Gross J, Ullrich T, Quentin M, Arsov C, Antoch G, Wittsack HJ, Schimmöller L. Role of arterial input function (AIF) for quantitative dynamic contrast-enhanced MRI to diagnose prostate cancer. DIR 2020
  • Ullrich T, Quentin M, Arsov C, Laqua N, Ziayee F, Abrar D, Hiester A, Blondin D, Rabenalt R, Albers P, Antoch G, Schimmöller L. Value of Dynamic Contrast Enhanced (DCE) MR Imaging in PI-RADS 4 Patients. RöFo 2019
  • Sawicki LM, Kirchner J, Buddensieck C, Antke C, Ullrich T, Schimmöller L, Boos J, Schleich C, Schaarschmidt BM, Buchbender C, Heusch P, Rabenalt R, Albers P, Antoch G, Müller HW, Hautzel H. Prospective comparison of whole-body MRI and 68Ga-PSMA PET/CT for the detection of biochemical recurrence of prostate cancer after radical prostatectomy. Eur J Nucl Med Mol Imaging 2019
  • Quentin M, Arsov C, Ullrich T, Valentin B, Hiester A, Blondin D, Antoch G, Schimmöller L. Comparison of analgesic techniques in MRI-guided in-bore prostate biopsy. Eur Radiol 2019
  • Hiester A, Nini A, Niegisch G, Arsov C, Hautzel H, Schimmöller L, Albers P, Rabenalt R. Oncological outcome of patients treated with spot-specific salvage lymphnode dissection (sLND) for positron-emission tomography (PET) positive prostate cancer (PCa) relapse. World J Urol 2019
  • Ullrich T, Arsov C, Quentin M, Laqua N, Klingebiel M, Martin O, Hiester A, Blondin D, Rabenalt R, Albers P, Antoch G, Schimmöller L. Analysis of PI-RADS 4 cases: Management recommendations for negatively biopsied patients. Eur J Radiol 2019; 113 (2019) 1–6
  • Ziayee F, Müller-Lutz A, Gross J, Quentin M, Ullrich T, Heusch P, Arsov C, Rabenalt R, Albers P, Antoch G, Wittsack HJ, Schimmöller L. Influence of arterial input function (AIF) on quantitative prostate dynamic contrast-enhanced (DCE) MRI and zonal prostate anatomy. Magn Reson Imaging 2019
  • Alberts A, Roobol M, Verbeek J, Schoots I, Chiu P, Osses D, Tijsterman J, Beerlage H, Mannaerts C, Schimmöller L, Albers P, Arsov C. Multivariable risk-based patient selection for prostate biopsy after magnetic resonance imaging:improving the European Randomized study of Screening for Prostate Cancer Risk Calculators by combining clinical parameters with the Prostate Imaging Reporting and Data System (PI-RADS) score. Eur Urol 2019; 75(2):310-318.
  • Ullrich T, Quentin M, Arsov C, Schmaltz AK, Tschischka A, Laqua N, Hiester A, Blondin D, Rabenalt R, Albers P, Antoch G, Schimmöller L. Risk stratification of ‘equivocal’ PI-RADS lesions in mp-MRI of the prostate. J Urol 2017; 199(3)
  • Ullrich T, Schimmöller L, Oymanns M, Dietzel F, Kirchner J, Arsov C, Rabenalt R, Blondin D, Albers P, Antoch G, Quentin M. Gegenwärtige Nutzung und Akzeptanz der multiparametrischen MRT in der Prostatakarzinomdiagnostik: Eine regionale Erfassung. RöFo 2018;190(5):419-426
  • Ullrich T, Quentin M, Schmaltz AK, Arsov C, Rubbert C, Blondin D, Rabenalt R, Albers P, Antoch G, Schimmöller L. Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRT of the prostate. Eur Radiol 2018; 28(1):17-23
  • Dimitroulis P, Rabenalt R, Nini A, Hiester A, Esposito I, Schimmöller L, Antoch G, Albers P, Arsov C. Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy-Are 2 Biopsy Cores per Magnetic Resonance Imaging Lesion Required? J Urol 2018; 200(5):1030-1034.
  • Ullrich T, Quentin M, Oelers C, Dietzel F, Sawicki LM, Arsov C, Rabenalt R, Albers P, Antoch G, Blondin D, Wittsack HJ, Schimmöller L. Magnetic resonance imaging of the prostate at 1.5 versus 3.0 T: A prospective comparison study of image quality. Eur J Radiol 2017; 90: 192–197
  • Franiel T, Quentin M, Mueller-Lisse UG, Schimmöller L, Asbach P, Rödel S, Willinek W, Hueper K, Beyersdorff D, Röthke M. MRI of the Prostate: Recommendations on Patient Preparation and Scanning Protocol. RöFo 2017; 189: 21–28
  • Schimmöller L, Quentin M, Blondin D, Dietzel F, Hiester A, Schleich C, Thomas C, Rabenalt R, Gabbert HE, Albers P, Antoch G, Arsov C. Targeted MR-guided prostate biopsy: Are two biopsy cores per MRI lesion required? Eur Radiol 2016
  • Schimmöller L, Blondin D, Arsov C, Rabenalt R, Albers P, Antoch G, Quentin M. MR-guided in-bore biopsy: Differences between prostate cancer detection and localization within primary and secondary biopsy settings. AJR 2016
  • Schimmöller L, Quentin M, Arsov C, Hiester A, Buchbender C, Rabenalt R, Albers P, Antoch G, Blondin D. MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy. Eur Radiol 2014
  • Schimmöller L, Quentin M, Arsov C, Hiester A, Kröpil P, Rabenalt R, Albers P, Antoch G, Blondin D. Predictive power of the ESUR scoring system for prostate cancer diagnosis verified with targeted MR-guided in-bore biopsy. Eur J Radiol 2014
  • Arsov C, Rabenalt R, Blondin D, Quentin M, Hiester A, Godehardt E, Gabbert HE, Antoch G, Albers P, Schimmöller L. Prospective randomized trial comparing MR-guided in-bore versus MRI/ultrasound fusion and TRUS-guided prostate biopsy in patients with prior negative biopsies. Eur Urol 2015
  • Quentin M, Blondin D, Arsov C, Schimmöller L, Hiester A, Godehardt E, Albers P, Antoch G, Rabenalt R. Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen. J Urol 2014; 192(5):1374-9
  • Arsov C, Rabenalt R, Quentin M, Hiester A, Blondin D, Albers P, Antoch G, Schimmöller L. Comparison of patient comfort between MR-guided in-bore and MRI/ultrasound fusion-guided prostate biopsy within a prospective randomized trial. World J Urol 2015
  • Arsov C, Becker N, Rabenalt R, Hiester A, Quentin M, Dietzel F, Gabbert HE, Antoch G, Albers P, Schimmöller L. The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy. J Canc Res Clin Oncol 2015
  • Quentin M, Schimmöller L, Arsov C, Rabenalt R, Antoch G, Albers P, Blondin D. Increased signal intensity of prostate lesions on high b-value diffusion-weighted images as a predictive sign of malignancy. Eur Radiol 2014
  • Quentin M, Pentang G, Schimmöller L, Kott O, Müller-Lutz A, Blondin D, Arsov C, Hiester A, Rabenalt R, Wittsack HJ. Feasibility of diffusional kurtosis tensor imaging in prostate MRI for the assessment of prostate cancer: preliminary results. Magn Reson Imaging 2014
  • Quentin M, Schimmöller L, Arsov C, Rabenalt R, Antoch G, Albers P, Blondin D. 3-T in-bore MR-guided prostate biopsy based on a scoring system for target lesions characterization. Acta Radiol 2013
  • Schimmöller L, Quentin M, Arsov C, Lanzman RS, Hiester A, Rabenalt R, Antoch G, Albers P, Blondin D. Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard. Eur Radiol 2013
MediathekInformation und Wissen
LageplanSo finden Sie uns